Jefferies upgrades Sartorius preferred shares, starts ordinary with 'buy'

Sartorius AG

12/08/2025 07:55

** Sartorius SATG.DE, SATG_p.DE is up around 3% in early Frankfurt trade after Jefferies initiates coverage on the ordinary shares of the German life sciences company with a "buy" recommendation and upgrades preferred ones to "buy" from "hold"

** The broker notes that the ordinary shares, which now account for just 7% of free float, could become more liquid in 2028 thanks to the planned dissolution of a family trust controlling the shares

** Jefferies maintains its "buy" rating on Sartorius' Paris-listed subsidiary Sartorius Stedim Biotech STDM.PA

** It says that investors are pricing in below-market growth for both Sartorius' preferred shares and Sartorius Stedim Biotech

** Up to the previous session's close, Sartorius' ordinary shares were down around 13%​ YTD

(Reporting by Cian Muenster)

((Cian.muenster@thomsonreuters.com))